{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:15:39Z","timestamp":1793312139319,"version":"4.5.0"},"reference-count":40,"publisher":"BMJ","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Community","award":["602783"],"award-info":[{"award-number":["602783"]}]},{"name":"European Community","award":["ID CAM-PaC"],"award-info":[{"award-number":["ID CAM-PaC"]}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["2017 PTCRC-Intra 2020"],"award-info":[{"award-number":["2017 PTCRC-Intra 2020"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["2018 ADVANCE"],"award-info":[{"award-number":["2018 ADVANCE"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["2022 CARESS"],"award-info":[{"award-number":["2022 CARESS"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca Corrente 2025"],"award-info":[{"award-number":["Ricerca Corrente 2025"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003395","name":"Shanghai Municipal Education Commission","doi-asserted-by":"publisher","award":["2021-01-07-00-02-E00090"],"award-info":[{"award-number":["2021-01-07-00-02-E00090"]}],"id":[{"id":"10.13039\/501100003395","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Startup Foundation for Young","award":["KJ3-0214-24-0013"],"award-info":[{"award-number":["KJ3-0214-24-0013"]}]},{"name":"Startup Foundation for Young","award":["Pa-CSC 233460"],"award-info":[{"award-number":["Pa-CSC 233460"]}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["82130074"],"award-info":[{"award-number":["82130074"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["82250710179"],"award-info":[{"award-number":["82250710179"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"crossref","award":["NNF21OC0068192"],"award-info":[{"award-number":["NNF21OC0068192"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"crossref","award":["NNF22OC0076055"],"award-info":[{"award-number":["NNF22OC0076055"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"crossref","award":["NNF23SA0087869"],"award-info":[{"award-number":["NNF23SA0087869"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Science and Technology Council (NSTC), Taiwan","award":["MOST 111-2314-B-039-056"],"award-info":[{"award-number":["MOST 111-2314-B-039-056"]}]},{"name":"National Science and Technology Council (NSTC), Taiwan","award":["NSTC 113-2314-B-039-073-MY3"],"award-info":[{"award-number":["NSTC 113-2314-B-039-073-MY3"]}]},{"name":"National Science and Technology Council (NSTC), Taiwan","award":["NSTC MY3"],"award-info":[{"award-number":["NSTC MY3"]}]},{"DOI":"10.13039\/100013297","name":"Eurostars","doi-asserted-by":"publisher","award":["114741 AS"],"award-info":[{"award-number":["114741 AS"]}],"id":[{"id":"10.13039\/100013297","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondazione AIRC per la ricerca","award":["IG 2023 ID 28933"],"award-info":[{"award-number":["IG 2023 ID 28933"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2026,6,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal cancers due to its aggressive biology and resistance to existing therapies. Oncofetal chondroitin sulfate (ofCS) is a tumour-restricted glycosaminoglycan broadly expressed across solid cancers but largely absent from normal adult tissues. We developed C9-based chimeric antigen receptor (CAR)-T cells targeting ofCS to overcome poor antigen specificity and the immunosuppressive tumour microenvironment (TME).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To optimise ofCS-targeted C9 CAR-T cell therapy for PDAC through integrated CAR design optimisation, metabolic enhancement and TME reprogramming.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>\n                      C9 and charge-optimised C9-66 CAR-T cells were engineered using a humanised ofCS-binding single-chain antibody fragment. Antitumour efficacy, functional durability and metabolic fitness were assessed in murine and patient-derived PDAC models. Enhancement strategies included inosine-mediated metabolic reprogramming,\n                      <jats:italic>Nr5a2<\/jats:italic>\n                      overexpression and sequential TME remodelling using GLP-1R modulation, CSF-1R blockade and programmed cell death protein-1 inhibition.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      C9 CAR-T cells exhibited potent cytotoxicity, delayed tumour progression and extended survival in PDAC models. Compared with the parental construct, charge-optimised C9-66 CAR-T cells showed reduced exhaustion and more sustained activity in vivo. Inosine enhanced cytokine production, promoted central-memory differentiation and mitigated exhaustion, whereas\n                      <jats:italic>Nr5a2<\/jats:italic>\n                      overexpression increased mitochondrial respiration and cytotoxicity. Sequential GLP-1R on\u2013off modulation with macrophage and checkpoint blockade enhanced intratumoural CAR-T cell activity and prolonged survival. Human C9-66 CAR-T cells retained specific ofCS recognition and lysed patient-derived PDAC cells in vitro and in vivo.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>C9-66 CAR-T cells with metabolic optimisation and TME reprogramming represent a tumour-specific and clinically translatable immunotherapeutic strategy for PDAC and other ofCS-expressing solid tumours.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2025-337545","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T17:25:28Z","timestamp":1784136328000},"page":"gutjnl-2025-337545","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Multimodal C9-66 CAR-T cell immunotherapy improves outcome in preclinical models of pancreatic cancer"],"prefix":"10.1136","clinical-trial-number":[{"clinical-trial-number":"nct06158139","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Ke","family":"Jiang","sequence":"first","affiliation":[{"name":"Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"State Key Laboratory of Systems Medicine for Cancer, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu-Hu","family":"Lai","sequence":"additional","affiliation":[{"name":"Precision Immunotherapy, Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Dong","sequence":"additional","affiliation":[{"name":"Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"State Key Laboratory of Systems Medicine for Cancer, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Pin","family":"Lee","sequence":"additional","affiliation":[{"name":"Precision Immunotherapy, Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan"},{"name":"Department of Medical Laboratory and Regenerative Medicine, MacKay Medical University, New Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Roberto","sequence":"additional","affiliation":[{"name":"Pancreatic Cancer Heterogeneity, INOC \u2013 Istituto Nazionale Oncologico Candiolo, IRCCS, Candiolo, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengli","family":"Yue","sequence":"additional","affiliation":[{"name":"Pancreatic Cancer Heterogeneity, INOC \u2013 Istituto Nazionale Oncologico Candiolo, IRCCS, Candiolo, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Tondi","sequence":"additional","affiliation":[{"name":"Pancreatic Cancer Heterogeneity, INOC \u2013 Istituto Nazionale Oncologico Candiolo, IRCCS, Candiolo, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Ping","family":"Chen","sequence":"additional","affiliation":[{"name":"Precision Immunotherapy, Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Wang","sequence":"additional","affiliation":[{"name":"Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"State Key Laboratory of Systems Medicine for Cancer, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeta","family":"Ananthanarayanan","sequence":"additional","affiliation":[{"name":"Pancreatic Cancer Heterogeneity, INOC \u2013 Istituto Nazionale Oncologico Candiolo, IRCCS, Candiolo, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Wang","sequence":"additional","affiliation":[{"name":"Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"State Key Laboratory of Systems Medicine for Cancer, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherry Yin-Yi","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Medicine, School of Medicine, China Medical University, Taichung, Taiwan"},{"name":"Department of Obstetrics and Gynecology, China Medical University Hospital, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette \u00d8","family":"Agerbaek","sequence":"additional","affiliation":[{"name":"Centre for Translational Medicine and Parasitology (CMP) at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark"},{"name":"VarCT Diagnostics, Frederiksberg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena E","family":"Vidal-Calvo","sequence":"additional","affiliation":[{"name":"Centre for Translational Medicine and Parasitology (CMP) at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark"},{"name":"VAR2 Pharmaceuticals, Frederiksberg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Choudhary","sequence":"additional","affiliation":[{"name":"Centre for Translational Medicine and Parasitology (CMP) at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark"},{"name":"VAR2 Pharmaceuticals, Frederiksberg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M","family":"Clausen","sequence":"additional","affiliation":[{"name":"Centre for Translational Medicine and Parasitology (CMP) at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark"},{"name":"Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California, USA"},{"name":"John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Esko","sequence":"additional","affiliation":[{"name":"Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Gustavsson","sequence":"additional","affiliation":[{"name":"Centre for Translational Medicine and Parasitology (CMP) at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark"},{"name":"VAR2 Pharmaceuticals, Frederiksberg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thor G","family":"Theander","sequence":"additional","affiliation":[{"name":"Centre for Translational Medicine and Parasitology (CMP) at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Salanti","sequence":"additional","affiliation":[{"name":"Centre for Translational Medicine and Parasitology (CMP) at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Aicher","sequence":"additional","affiliation":[{"name":"Precision Immunotherapy, Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1158-8554","authenticated-orcid":false,"given":"Christopher","family":"Heeschen","sequence":"additional","affiliation":[{"name":"Pancreatic Cancer Heterogeneity, INOC \u2013 Istituto Nazionale Oncologico Candiolo, IRCCS, Candiolo, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"2026071510251811000_gutjnl-2025-337545v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30974-0"},{"key":"2026071510251811000_gutjnl-2025-337545v1.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200694"},{"key":"2026071510251811000_gutjnl-2025-337545v1.3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejca.2023.04.012","article-title":"Efficacy of immune checkpoint inhibitors in microsatellite unstable\/mismatch repair-deficient advanced pancreatic adenocarcinoma: an AGEO European Cohort","volume":"188","author":"Ta\u00efeb","year":"2023","journal-title":"Eur J Cancer"},{"key":"2026071510251811000_gutjnl-2025-337545v1.4","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01829-9"},{"key":"2026071510251811000_gutjnl-2025-337545v1.5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-265041"},{"key":"2026071510251811000_gutjnl-2025-337545v1.6","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jtct.2022.06.019","article-title":"Role of CD19 Chimeric Antigen Receptor T Cells in Second-Line Large B Cell Lymphoma: Lessons from Phase 3 Trials. An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy","volume":"28","author":"Perales","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"2026071510251811000_gutjnl-2025-337545v1.7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15030663","article-title":"CAR-T: What Is Next?","volume":"15","author":"Chen","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2026071510251811000_gutjnl-2025-337545v1.8","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1038\/s41591-024-03037-z","article-title":"Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results","volume":"30","author":"Qi","year":"2024","journal-title":"Nat Med"},{"key":"2026071510251811000_gutjnl-2025-337545v1.9","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1200\/JCO.23.02314","article-title":"Safety and Efficacy of CT041 in Patients With Refractory Metastatic Pancreatic Cancer: A Pooled Analysis of Two Early-Phase Trials","volume":"42","author":"Qi","year":"2024","journal-title":"J Clin Oncol"},{"key":"2026071510251811000_gutjnl-2025-337545v1.10","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-023-04292-3","article-title":"Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments","volume":"21","author":"Dagar","year":"2023","journal-title":"J Transl Med"},{"key":"2026071510251811000_gutjnl-2025-337545v1.11","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316595"},{"key":"2026071510251811000_gutjnl-2025-337545v1.12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101391","article-title":"The specificity of the malarial VAR2CSA protein for chondroitin sulfate depends on 4-O-sulfation and ligand accessibility","volume":"297","author":"Spliid","year":"2021","journal-title":"J Biol Chem"},{"key":"2026071510251811000_gutjnl-2025-337545v1.13","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-018-0086-z"},{"key":"2026071510251811000_gutjnl-2025-337545v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2015.09.003"},{"key":"2026071510251811000_gutjnl-2025-337545v1.15","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23254-1","article-title":"Cryo-EM reveals the architecture of placental malaria VAR2CSA and provides molecular insight into chondroitin sulfate binding","volume":"12","author":"Wang","year":"2021","journal-title":"Nat Commun"},{"key":"2026071510251811000_gutjnl-2025-337545v1.16","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05793-2","article-title":"The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner","volume":"9","author":"Agerb\u00e6k","year":"2018","journal-title":"Nat Commun"},{"key":"2026071510251811000_gutjnl-2025-337545v1.17","doi-asserted-by":"crossref","first-page":"188868","DOI":"10.1016\/j.bbcan.2023.188868","article-title":"Liquid biopsy in pancreatic cancer - Current perspective and future outlook","volume":"1878","author":"Zhao","year":"2023","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2026071510251811000_gutjnl-2025-337545v1.18","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-51781-0","article-title":"Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfate","volume":"15","author":"Vidal-Calvo","year":"2024","journal-title":"Nat Commun"},{"key":"2026071510251811000_gutjnl-2025-337545v1.19","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-023-00789-0"},{"key":"2026071510251811000_gutjnl-2025-337545v1.20","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-020-0889-6"},{"key":"2026071510251811000_gutjnl-2025-337545v1.21","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.177141","article-title":"Enhancing CAR-T cell metabolism to overcome hypoxic conditions in the brain tumor microenvironment","volume":"9","author":"Hatae","year":"2024","journal-title":"JCI Insight"},{"key":"2026071510251811000_gutjnl-2025-337545v1.22","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2024.101400","article-title":"Inhibition of CD38 enzymatic activity enhances CAR-T cell immune-therapeutic efficacy by repressing glycolytic metabolism","volume":"5","author":"Huang","year":"2024","journal-title":"Cell Rep Med"},{"key":"2026071510251811000_gutjnl-2025-337545v1.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01918-6"},{"key":"2026071510251811000_gutjnl-2025-337545v1.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.01.002"},{"key":"2026071510251811000_gutjnl-2025-337545v1.25","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s42255-020-0219-4","article-title":"Inosine is an alternative carbon source for CD8+-T-cell function under glucose restriction","volume":"2","author":"Wang","year":"2020","journal-title":"Nat Metab"},{"key":"2026071510251811000_gutjnl-2025-337545v1.26","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-52503-2","article-title":"Histone marks identify novel transcription factors that parse CAR-T subset-of-origin, clinical potential and expansion","volume":"15","author":"Fiorenza","year":"2024","journal-title":"Nat Commun"},{"key":"2026071510251811000_gutjnl-2025-337545v1.27","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-1677"},{"key":"2026071510251811000_gutjnl-2025-337545v1.28","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0010-1"},{"key":"2026071510251811000_gutjnl-2025-337545v1.29","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav9732","article-title":"The orphan nuclear receptor LRH-1\/NR5a2 critically regulates T cell functions","volume":"5","author":"Seitz","year":"2019","journal-title":"Sci Adv"},{"key":"2026071510251811000_gutjnl-2025-337545v1.30","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1038\/s44321-024-00153-8","article-title":"Transient CAR T cells with specificity to oncofetal glycosaminoglycans in solid tumors","volume":"16","author":"Khazamipour","year":"2024","journal-title":"EMBO Mol Med"},{"key":"2026071510251811000_gutjnl-2025-337545v1.31","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-023-02883-y","article-title":"Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2\/MYC signaling and restoring chemosensitivity","volume":"42","author":"Zheng","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"2026071510251811000_gutjnl-2025-337545v1.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2019.07.015"},{"key":"2026071510251811000_gutjnl-2025-337545v1.33","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s43018-026-01124-3","article-title":"Hypoxia-responsive CEA-targeted CAR T cells in CEA-positive solid tumors through intraperitoneal or intravenous infusion: a phase 1 trial","volume":"7","author":"Gao","year":"2026","journal-title":"Nat Cancer"},{"key":"2026071510251811000_gutjnl-2025-337545v1.34","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-023-01491-9","article-title":"CT041 CAR T cell therapy for Claudin18.2-positive metastatic pancreatic cancer","volume":"16","author":"Qi","year":"2023","journal-title":"J Hematol Oncol"},{"key":"2026071510251811000_gutjnl-2025-337545v1.35","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-017-0440-4"},{"key":"2026071510251811000_gutjnl-2025-337545v1.36","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-53220-6","article-title":"PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial","volume":"15","author":"Stein","year":"2024","journal-title":"Nat Commun"},{"key":"2026071510251811000_gutjnl-2025-337545v1.37","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1805-z"},{"key":"2026071510251811000_gutjnl-2025-337545v1.38","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abk1900","article-title":"TSTEM-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models","volume":"15","author":"Meyran","year":"2023","journal-title":"Sci Transl Med"},{"key":"2026071510251811000_gutjnl-2025-337545v1.39","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.cell.2026.02.004","article-title":"\u03b2-hydroxybutyrate enhances the metabolic fitness of CAR T cells in cancer","volume":"189","author":"Liu","year":"2026","journal-title":"Cell"},{"key":"2026071510251811000_gutjnl-2025-337545v1.40","doi-asserted-by":"crossref","DOI":"10.1172\/JCI179014","article-title":"Off-the-shelf invariant NKT cells expressing anti-PSCA CAR and IL-15 promote pancreatic cancer regression in mice","volume":"135","author":"Dai","year":"2025","journal-title":"J Clin Invest"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2025-337545","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T17:25:33Z","timestamp":1784136333000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2025-337545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":40,"alternative-id":["10.1136\/gutjnl-2025-337545"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2025-337545","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]}}}